| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Okt―22 |
The Effect of SARS-COV-2 Protein Fragments on the Dimerization of α-Synuclein |
Lucy M. Coleman, Ulrich H. E. Hansmann |
| 2 |
[GO] |
2025―Aug―22 |
An Amyloidogenic Fragment of the Spike Protein from SARS-CoV-2 Virus Stimulates the Aggregation and Toxicity of Parkinson’s Disease Protein Alpha-Synuclein |
João Flavio Gemignani, Paulo Augusto Netz, Daniel Izecksohn, David Dabkiewicz, Ming-Hao Li, Adalgisa Felippe Wiecikowski, David Eliezer, Yraima Cordeiro, Cristian Follmer |
| 3 |
[GO] |
2024―Nov―25 |
Effect of a SARS-CoV-2 Protein Fragment on the Amyloidogenic Propensity of Human Islet Amyloid Polypeptide |
Marvin Bilog, Jennifer Cersosimo, Iliana Vigil, Ruel Z. B. Desamero, Adam A. Profit |
| 4 |
[GO] |
2024―Nov―08 |
SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein Depletion |
Wanda Christ, Sebastian Kapell, Michal J. Sobkowiak, Georgios Mermelekas, Björn Evertsson, Helena Sork, Osama Saher, Safa Bazaz, Oskar Gustafsson, Eduardo I. Cardenas, Viviana Villa, Roberta Ricciarelli, Johan K. Sandberg, Jonas Bergquist, Andrea Sturchio, Per Svenningsson, Tarja Malm, Alberto J. Espay, Maria Pernemalm, Anders Lindén, Jonas Klingström, Samir El Andaloussi, Kariem Ezzat |
| 5 |
[GO] |
2023―Dez―22 |
SARS-CoV-2-Mimicking Pseudoviral Particles Accelerate α-Synuclein Aggregation In Vitro |
Gianluca Zilio, Anna Masato, Michele Sandre, Alberto Caregnato, Francesca Moret, Agnieszka Katarzyna Maciola, Angelo Antonini, Marco Brucale, Laura Cendron, Nicoletta Plotegher, Luigi B뫌o |
| 6 |
[GO] |
2023―Sep―12 |
Intranasal Route: A Nasocerebral Approach against SARS-CoV-2 in NeuroCOVID |
Abdul Mannan Baig, Joachim Gerlach |
| 7 |
[GO] |
2023―Mai―12 |
ACE2 Receptor and TMPRSS2 Protein Expression Patterns in the Human Brainstem Reveal Anatomical Regions Potentially Vulnerable to SARS-CoV-2 Infection |
Aron Emmi, Aleksandar Tushevski, Alessandro Sinigaglia, Silvia Barbon, Michele Sandre, Elena Stocco, Veronica Macchi, Angelo Antonini, Luisa Barzon, Andrea Porzionato, Raffaele De Caro |
| 8 |
[GO] |
2023―Feb―06 |
SARS-CoV-2 Spike Protein Downregulates Cell Surface α7nAChR through a Helical Motif in the Spike Neck |
Tommy S. Tillman, Qiang Chen, Vasyl Bondarenko, Jonathan A. Coleman, Yan Xu, Pei Tang |
| 9 |
[GO] |
2022―Okt―03 |
Underlying Causes and Treatment Modalities for Neurological Deficits in COVID-19 and Long-COVID |
Abdul Mannan Baig, Nigel H. Greig, Joachim Gerlach, Prakash Salunke, Mark Fabrowski, Valentina Viduto, Tazeen Ali |
| 10 |
[GO] |
2022―Apr―02 |
Correlating Biochemical and Structural Changes in the Brain with Clinical Features in COVID-19 |
Abdul Mannan Baig |
| 11 |
[GO] |
2022―Jan―20 |
Mitochondrial Dysfunction: A Prelude to Neuropathogenesis of SARS-CoV-2 |
Artem Pliss, Andrey N. Kuzmin, Paras N. Prasad, Supriya D. Mahajan |
| 12 |
[GO] |
2021―Dez―03 |
Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation |
Slav A. Semerdzhiev, Mohammad A. A. Fakhree, Ine Segers-Nolten, Christian Blum, Mireille M. A. E. Claessens |
| 13 |
[GO] |
2021―Nov―15 |
Pathways and Pathogenesis of Hearing Deficits, Tinnitus, and Vertigo in COVID-19 |
Abdul Mannan Baig |
| 14 |
[GO] |
2021―Okt―06 |
Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments |
Raziyeh Najafloo, Jila Majidi, Alimohamad Asghari, Mina Aleemardani, Seyed Kamran Kamrava, Sara Simorgh, Amelia Seifalian, Zohreh Bagher, Alexander M. Seifalian |
| 15 |
[GO] |
2021―Sep―17 |
The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia |
Christopher S. von Bartheld, Molly M. Hagen, Rafal Butowt |
| 16 |
[GO] |
2021―Aug―03 |
Brain Imaging in COVID-19 |
Avantika Samkaria, Pravat Kumar Mandal |
| 17 |
[GO] |
2021―Jul―14 |
Neurological Manifestations in COVID-19 Patients: A Meta-Analysis |
Vitalakumar D, Ankita Sharma, Anoop Kumar, S. J. S. Flora |
| 18 |
[GO] |
2021―Jul―06 |
Targeting Neuroinvasion by SARS-CoV-2: Emerging Trends in Drug and Antibody Delivery to Combat COVID-19 |
Abdul Mannan Baig |
| 19 |
[GO] |
2021―Jul―02 |
COVID-19 as a Trigger of Brain Autoimmunity |
Mayuri Gupta, Donald F. Weaver |
| 20 |
[GO] |
2021―Jul―01 |
Comment on “Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak” |
Omar Rabab’h, Ali Al-Ramadan, Abeer Gharaibeh |
| 21 |
[GO] |
2021―Jun―08 |
Inflammatory Response Leads to Neuronal Death in Human Post-Mortem Cerebral Cortex in Patients with COVID-19 |
Mahdi Eskandarian Boroujeni, Leila Simani, Hans A. R. Bluyssen, Hamid Reza Samadikhah, Soheila Zamanlui Benisi, Sanaz Hassani, Nader Akbari Dilmaghani, Mobina Fathi, Kimia Vakili, Gholam-Reza Mahmoudiasl, Hojjat Allah Abbaszadeh, Meysam Hassani Moghaddam, Mohammad-Amin Abdollahifar, Abbas Aliaghaei |
| 22 |
[GO] |
2021―Mrz―31 |
Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry |
Samantha Perez-Miller, Marcel Patek, Aubin Moutal, Paz Duran, Carly R. Cabel, Curtis A. Thorne, Samuel K. Campos, Rajesh Khanna |
| 23 |
[GO] |
2021―Feb―19 |
Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine |
Kartikay Prasad, Shahzaib Ahamad, Hema Kanipakam, Dinesh Gupta, Vijay Kumar |
| 24 |
[GO] |
2021―Feb―10 |
Chemosensory Systems in COVID-19: Evolution of Scientific Research |
Sheila Veronese, Andrea Sbarbati |
| 25 |
[GO] |
2021―Feb―02 |
Regeneration Profiles of Olfactory Epithelium after SARS-CoV-2 Infection in Golden Syrian Hamsters |
Shinji Urata, Junki Maruyama, Megumi Kishimoto-Urata, Rachel A. Sattler, Rebecca Cook, Nantian Lin, Tatsuya Yamasoba, Tomoko Makishima, Slobodan Paessler |
| 26 |
[GO] |
2020―Dez―18 |
Could Simultaneous Nasal and Oral Irrigation Be a Nontherapeutic Tool against SARS-CoV-2? |
Bharat Baruah |
| 27 |
[GO] |
2020―Dez―05 |
Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome |
Abdul Mannan Baig |
| 28 |
[GO] |
2020―Dez―03 |
Could Artesunate Have a Positive Effect on the Neurological Complications Related to Infection When It Is Used in the Treatment of COVID-19? |
Tuğçenur Uzun, Orçun Toptaş, Şule Aydın Türkoğlu |
| 29 |
[GO] |
2020―Nov―27 |
Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and α-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders |
Cristian Follmer |
| 30 |
[GO] |
2020―Nov―16 |
COVID-19 and Body Iron: A Survey on Phenomenological and Genetic Correlations |
Rüdiger Lawaczeck |
| 31 |
[GO] |
2020―Nov―05 |
COVID-19: Oxidative Preconditioning as a Potential Therapeutic Approach |
Rachid Akki, Nada Fath, Hicham Mohti |
| 32 |
[GO] |
2020―Nov―04 |
Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection |
Omid Tavassoly, Farinaz Safavi, Iman Tavassoly |
| 33 |
[GO] |
2020―Nov―03 |
Toward COVID-19 Therapeutics: A Viewpoint from the Nonprotein Amino Acid Based Synthetic Peptide Design Approach |
Sayan Bhattacharjee |
| 34 |
[GO] |
2020―Okt―29 |
Can Neurotropic Free-Living Amoeba Serve as a Model to Study SARS-CoV-2 Pathogenesis? |
Abdul Mannan Baig |
| 35 |
[GO] |
2020―Okt―08 |
Covert Pathways to the Cranial Cavity: Could These Be Potential Routes of SARS-CoV-2 to the Brain? |
Abdul Mannan Baig |
| 36 |
[GO] |
2020―Sep―30 |
Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor |
Rafal Butowt, Katarzyna Bilinska, Christopher S. Von Bartheld |
| 37 |
[GO] |
2020―Sep―29 |
SARS-CoV-2: Disinfection Strategies to Prevent Transmission of Neuropathogens via Air Conditioning Systems |
Ruqaiyyah Siddiqui, Mustafa Khamis, Taleb Ibrahim, Naveed Ahmed Khan |
| 38 |
[GO] |
2020―Sep―23 |
Brain and COVID-19 crosstalk: pathophysiological and psychological manifestations |
Kalyani Verma, Amitabh ., Dipti N. Prasad, Bhuvnesh Kumar, Ekta Kohli |
| 39 |
[GO] |
2020―Sep―18 |
Irrigation System and COVID-19 Recurrence: A Potential Risk Factor in the Transmission of SARS-CoV-2 |
Ruqaiyyah Siddiqui, Mustafa Khamis, Taleb Ibrahim, Naveed Ahmed Khan |
| 40 |
[GO] |
2020―Sep―03 |
Correlation between CNS Tuberculosis and the COVID-19 Pandemic: The Neurological and Therapeutic Insights |
Narattam Mandal, Nayan De, Pulak Jana, Achinta Sannigrahi, Krishnananda Chattopadhyay |
| 41 |
[GO] |
2020―Sep―01 |
Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences |
CHRISTOPHER S. VON BARTHELD, Molly M. Hagen, Rafal Butowt |
| 42 |
[GO] |
2020―Aug―26 |
Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses |
Francisco J. Barrantes |
| 43 |
[GO] |
2020―Aug―25 |
iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2 |
Xiao-Yuan Mao, Wei-Lin Jin |
| 44 |
[GO] |
2020―Aug―13 |
SARS-CoV-2: The Increasing Importance of Water Filtration against Highly Pathogenic Microbes |
Ruqaiyyah Siddiqui, Mustafa Khamis, Taleb Ibrahim, Naveed Ahmed Khan |
| 45 |
[GO] |
2020―Aug―04 |
Taste and smell disorders in COVID-19 patients: role of Interleukin-6 |
Angela Pia Cazzolla, Roberto Lovero, Lorenzo Lo Muzio, Nunzio Francesco Testa, Annalisa Schirinzi, Giuseppe Palmieri, Pietro Pozzessere, Vito Procacci, Mariasevera Di Comite, Domenico Ciavarella, Maria Teresa Pepe, Caterina De Ruvo, Vito Crincoli, Francesca Di Serio, Luigi Santacroce |
| 46 |
[GO] |
2020―Jul―27 |
Fragile Endothelium and Brain Dysregulated Neurochemical Activity in COVID-19 |
Abdulrahman Alharthy, Fahad Faqihi, Ziad A. Memish, Dimitrios Karakitsos |
| 47 |
[GO] |
2020―Jul―27 |
Homo sapiens versus SARS-CoV-2 |
Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
| 48 |
[GO] |
2020―Jul―24 |
Lung Injury in COVID-19-An Emerging Hypothesis |
Abdulrahman Alharthy, Fahad Faqihi, Ziad A. Memish, Dimitrios Karakitsos |
| 49 |
[GO] |
2020―Jul―16 |
Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism |
Katarzyna Bilinska, Rafal Butowt |
| 50 |
[GO] |
2020―Jul―14 |
Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer’s Dementia Patients with SARS-CoV-2 Infection |
Chhanda Charan Danta |
| 51 |
[GO] |
2020―Jul―14 |
Can the Environmental Phagocyte Acanthamoeba Be a Useful Model to Study SARS-CoV-2 Pathogenicity, Infectivity, and Evasion of Cellular Immune Defenses? |
Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
| 52 |
[GO] |
2020―Jul―08 |
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection |
Chhanda Charan Danta |
| 53 |
[GO] |
2020―Jul―06 |
Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms |
Kambiz Hassanzadeh, Helena Perez Pena, Jessica Dragotto, Lucia Buccarello, Federico Iorio, Stefano Pieraccini, Giulio Sancini, Marco Feligioni |
| 54 |
[GO] |
2020―Jul―01 |
Taste and Smell Impairment in SARS-CoV-2 Recovers Early and Spontaneously: Experimental Data Strongly Linked to Clinical Data |
Ibrahim Sayin, Zahide Mine Yazici |
| 55 |
[GO] |
2020―Jun―30 |
Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19 |
Abdul Mannan Baig |
| 56 |
[GO] |
2020―Jun―12 |
Happy Hypoxemia in COVID-19-A Neural Hypothesis |
Anoop U.R., Kavita Verma |
| 57 |
[GO] |
2020―Jun―11 |
Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia |
Abolfazl Torabi, Esmaeil Mohammadbagheri, Nader Akbari Dilmaghani, Amir-Hossein Bayat, Mobina Fathi, Kimia Vakili, Rafieh Alizadeh, Omidvar Rezaeimirghaed, Mohammadreza Hajiesmaeili, Mahtab Ramezani, Leila Simani, Abbas Aliaghaei |
| 58 |
[GO] |
2020―Jun―11 |
Targeting SARS-CoV-2: Novel Source of Antiviral Compound(s) against COVID-19? |
Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
| 59 |
[GO] |
2020―Jun―03 |
SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis. |
Chitra Mohinder Singh Singal, Paritosh Jaiswal, Pankaj Seth |
| 60 |
[GO] |
2020―Jun―02 |
Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak |
Xi-Xi Yin, Xiang-Rong Zheng, Wang Peng, Mao-Lan Wu, Xiao-Yuan Mao |
| 61 |
[GO] |
2020―Mai―29 |
Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19 |
Abdul Mannan Baig, Erin C. Sanders |
| 62 |
[GO] |
2020―Mai―26 |
Immunity-Boosting Spices and the Novel Coronavirus |
Yehya Elsayed, Naveed Ahmed Khan |
| 63 |
[GO] |
2020―Mai―20 |
Proposed Intranasal Route for Drug Administration in the Management of Central Nervous System Manifestations of COVID-19 |
Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
| 64 |
[GO] |
2020―Mai―19 |
Autonomic Brain Centers and Pathophysiology of COVID-19 |
Fatiha Chigr, Mohamed Merzouki, Mohamed Najimi |
| 65 |
[GO] |
2020―Mai―07 |
Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. |
Katarzyna Bilinska, Patrycja Jakubowska, CHRISTOPHER S. VON BARTHELD, Rafal Butowt |
| 66 |
[GO] |
2020―Apr―29 |
Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? |
Sonu Gandhi, Amit Kumar Srivastava, Upasana Ray, Prem Prakash Tripathi |
| 67 |
[GO] |
2020―Apr―28 |
Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement |
Abdul Mannan Baig |
| 68 |
[GO] |
2020―Apr―22 |
Neurological Insights of COVID-19 Pandemic |
Gaurav Das, Nabanita Mukherjee, Surajit Ghosh |
| 69 |
[GO] |
2020―Apr―13 |
War on Terror Cells: Strategies to Eradicate “Novel Coronavirus” Effectively |
Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
| 70 |
[GO] |
2020―Mrz―31 |
Is Regional Anesthesia Enough Safe in Suspected or Confirmed COVID-19 Patients? |
Reza Aminnejad, Hamed Shafiee |
| 71 |
[GO] |
2020―Mrz―13 |
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms |
Abdul Mannan Baig, Areeba Khaleeq, Usman Ali, Hira Syeda |
